The AMDA is excited to announce that “Inspired by Pompe—High Protein, Reduced Carb Cooking” Cookbooks are availble for sale. This

Reveglucosidase Alfa Trends Positive in Respiratory Muscle Strength and Endurance Endpoints in Patients Previously Treated With EnzymeA protein that helps the body carry out chemical reactions. Replacement Therapy SAN

The AMDA is excited to announce that the 2016 PCMA of Texas Pull for Pompe will take place on Saturday,

CRANBURY, N.J., Dec. 22, 2015 (GLOBE NEWSWIRE)—Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of rare and orphan diseases,

The sixth annual AMDA Research Grant (the 2015 Helen Walker Research Grant) was awarded to Dr. Rosa Puertollano and Dr.

For the twentieth (20th) anniversary of the AMDA, we will be hosting an International Patient and Scientific Conference in San

The AMDA is excited to announce a research grant opportunity for applicants who are involved in Pompe DiseaseA rare genetic disease in which the body cannot properly break down glycogen, leading to buildup that damages muscles and can affect breathing and, in some cases, the heart. research. This

We are excited to announce that Registration is now open for the 2015 AMDA International Pompe Patient and Scientific Conference!

Please click here to read the press release.

The AMDA is excited to announce that in collaboration with Genzyme Corporation, AMDA President and IPA Chair, Tiffany House, participated